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Summary
Respiratory disease is common in children and strongly
associated with lifestyle and environmental exposures.
Thus, it is important to study the epidemiology locally. The
LuftiBus in the School (LUIS) study was set up to assess
the respiratory health of schoolchildren in the canton of
Zurich, Switzerland.
LUIS is a cross-sectional population-based study that was
carried out 2013 to 2016. Children aged 6–17 years living
in the canton of Zurich were eligible to participate. All
schools in the canton were approached and the school
head decided whether the school would participate and
with which classes. Consenting parents answered a stan-
dardised questionnaire at home and assenting children
completed a shorter questionnaire by interview at school.
Trained technicians measured children’s lung function, in-
cluding spirometry, double tracer gas single-breath
washout (DTG-SBW) and fractional exhaled nitric oxide
(FeNO). Address histories of participants were geocoded
to be linked with area-based socioeconomic measures
and environmental exposures such as spatiotemporal air
pollution estimates for specific time periods and locations.
A subgroup was seen again 12 months later using the
same procedures to collect longitudinal data.
The study included 3870 children at baseline and 655 at
the 1-year follow-up. Median age was 12.7 years; 281
(8%) had wheezed in the past year. At baseline we col-
lected 3457 (89%) parental and 3546 (92%) child ques-
tionnaires, and 3393 (88%) FeNO, 3446 (89%) spirometry,
and 1795 (46%) DTG-SBW measurements.
LUIS is a rich resource of health-related data, with in-
formation on lung function, environmental exposures and
respiratory health on Swiss schoolchildren.
Introduction
Respiratory disease is common and can affect quality of
life and school performance in children [1]. Symptoms and
diseases result from complex interactions between genet-
ic factors and modifiable behavioural and environmental
influences, such as physical activity, passive and active
smoking, and air pollution [2]. The prevalence of respira-
tory symptoms such as wheeze and cough varies widely
between countries, so local studies are important [3, 4].
Geographic differences in the prevalence of respiratory
diseases may result from differences in lifestyle, health
care, socioeconomic factors and environmental exposures,
which have been the focus of many studies [2, 3, 5–7].
Previous research on the respiratory health of Swiss chil-
dren focused on self-reported lower respiratory symptoms
and a farming environment [8–14]. None of the recent
population-based studies included a detailed assessment of
lung function and airway inflammation. Different exami-
nations measure diverse aspects of lung physiology, such
as airway inflammation, lung volumes, flows represent-
ing function of larger airways, and ventilation inhomo-
geneity representing the ventilation in peripheral airways.
The same symptom might be caused by different underly-
ing mechanisms, and similar underlying mechanisms may
cause diverse symptoms in children. Thus, joint evalua-
tion of results from different examinations and of reported
symptoms would improve understanding of this complexi-
ty. This article explains the methodology of LuftiBus in the
School (LUIS) and presents first results.
Study objectives
LUIS is a multipurpose school-based study on respiratory
health in children. Its objectives are: (1) to describe the
frequency of common upper and lower respiratory symp-
toms such as chronic cough, rhinitis, habitual snoring and
wheeze reported by schoolchildren and their parents; (2)
*
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to assess risk factors for respiratory symptoms, with a spe-
cial interest in lifestyle and environmental exposures such
as smoking and air pollution; (3) to study lung function
phenotypes, determinants of lung function and associations
with lifestyle and environmental exposures; (4) to assess
the distribution of lung function (spirometry and double
tracer gas single breath washout, [DTG-SBW]) and air-
way inflammation (fractional exhaled nitric oxide [FeNO])
measurements in healthy schoolchildren and to provide
normative data; (5) to gain methodological insights into
questionnaire design and performance of novel lung func-
tion tests such as DTG-SBW in school-based settings to
help guide future research.
Materials and methods
Study design and setting
Throughout the manuscript we use the past tense for pro-
cedures or analyses that were done in the past and the pre-
sent or future tense for those that are underway or planned.
LUIS is a cross-sectional study that was conducted from
November 2013 to December 2016 among schoolchildren
aged 6 to 17 years living in the canton of Zurich (Clinical-
Trials.gov: NCT03659838). A subsample of children was
seen again 1 year later for collection of longitudinal data.
The canton of Zurich is located in the north-eastern part of
Switzerland and is the most populated canton in the coun-
try with over 1.5 million inhabitants, 18% of the Swiss
population [15].
Study procedures
LUIS was embedded in a respiratory health promotion ac-
tivity offered by Lunge Zürich [16-18]. Lunge Zürich is
a non-profit organisation that promotes respiratory health
prevention and research [16]. LUIS used a special bus from
Lunge Zürich, the LuftiBus, to visit schools within the can-
ton of Zurich, further details on the LuftiBus are described
in the appendix [16]. All school heads in the canton of
Zurich were invited to participate (fig. 1). They decided
whether to take part in the project and with which class-
es, independently of the health status on the students. Par-
ticipating schools contributed CHF 500 for a 2-day visit
and CHF 800 for a visit lasting 1 week, from their reserved
budget for health prevention activities in schools. Main
reasons for non-participation of schools were lack of time
and commitment to other health prevention activities. The
study coordinator provided the participating schools with
closed envelopes containing study information for parents
and for children, and an informed consent form and a ques-
tionnaire for parents. Teachers gave these envelopes to the
students 2 weeks before the visit. Parents were asked to
complete the questionnaire. Two study field workers, who
were trained lung function technicians, visited each school
with the study bus, the LuftiBus [16]. They collected the
parental questionnaires and consent forms from the teach-
ers and asked all students for oral and, where appropriate,
written consent. The study bus contained computers and
equipment for lung function testing. One field worker mea-
sured the children’s height and weight and performed the
lung function tests, and the other interviewed the children
using a short electronic questionnaire.
Where the heads of the participating schools agreed, the
school was visited again 1 year later (2015–2016), with the
same procedures and the same tests as in the baseline visit.
Study participants
Eligible were children aged 6 to 17 years, living in the can-
ton of Zurich with consent to participate. Participants were
recruited from whole school classes selected for participa-
tion by the heads of participating schools. There were no
predefined exclusion criteria. However, basic German lan-
guage knowledge from the children and their parents was
required to understand the study information and to com-
plete the questionnaires.
Figure 1: Design of the LuftiBus in the school (LUIS) study.
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Data collection
The questionnaires
The study used two questionnaires: one for parents and one
for children. Both included questions on respiratory symp-
toms and diagnoses including the key questions from the
International Study on Asthma and Allergies in Childhood
study and additional questions from the Leicester Respira-
tory Cohort questionnaires [3, 7]. The questionnaire to par-
ents included questions about frequency, duration, severi-
ty and triggers of upper and lower respiratory symptoms,
doctors’ diagnosis of asthma, medication, environmental
factors, household characteristics, family history of asth-
ma, and current and past addresses (table 1). We geocod-
ed participant’s addresses using a reference file from the
Swiss Federal Statistical Office (Neuchâtel) [15]. The data
from the parental questionnaire were entered into an Epi-
data database (version 4.2.0.0, EpiData Association, Den-
mark) at the Institute for Social and Preventive Medicine
(ISPM) in Bern.
Children replied to the questionnaire via interview by the
field workers in the bus. It included questions about current
respiratory health such as rhinitis, cough and wheeze, the
presence of cough or a cold on the day of the school visit,
inhaled or oral asthma medication on the day of the visit,
active smoking and parental smoking. To help the children
correctly report asthma medications, the field workers used
a poster with pictures and commercial names of all com-
monly used inhaled and oral medications in Switzerland
(supplementary fig. S1). Children’s answers were direct-
ly entered by field workers into the web-based Research
Electronic Data Capture (REDCap) database [19].
Area-based index of socioeconomic position in Switzer-
land (Swiss-SEP)
The Swiss-SEP was developed by the Swiss National Co-
hort (SNC) as an area-based measure of socioeconomic
status that incorporates information on rent per square me-
ter, education and occupation of household heads, and
number of persons per household room [20, 21]. The
Swiss-SEP ranges from 0 (lowest) to 100 (highest). We
estimated the Swiss-SEP for our participants by matching
the geocodes of our participants addresses to the nearest
geocode in the Swiss-SEP dataset. If the address of a par-
ticipant was missing, we assigned the median Swiss-SEP
among participants of the same school. In this manuscript
we used a dataset from the SNC to assess the distribution
of Swiss-SEP among households from the canton of Zurich
with at least one child in school-age (6–17 years) and com-
pared it with the distribution of Swiss-SEP of our study
participants.
Lung function measurements
Children’s standing height and weight were measured
without shoes and recorded in the spirometry database.
Lung function tests were performed inside the bus in the
Table 1: Details of data collected in the LuftiBus in the school (LUIS) study.
Data sources Collected data
1. Questionnaires For parents Upper and lower respiratory symptoms in the past 12 months: colds, rhinitis, snoring, cough, wheeze, fre-
quency of wheeze/asthma attacks, triggers of cough and wheeze [3, 7]
Asthma diagnosis and hay fever [3, 7]
Management of wheeze/asthma in the past 12 months: number of doctor visits; medication use including
short- and long-acting beta-2 agonists, inhaled corticosteroids, leukotriene receptor antagonists, and antihist-
amines
Household: Current and past address, living on which floor, type of cooking stove, presence of oven or chim-
ney, living on a farm
Environment and lifestyle: paternal and maternal smoking indoors or outdoors and number of cigarettes
smoked, physical activity of the child, type of commuting to school, sports outside school, pets at home
Family: country of birth of the child, country of origin of the parents, siblings, parental education, parental his-
tory of asthma and chronic cough
For children Currently having a cold; currently coughing
Upper and lower respiratory symptoms in the past 12 months: colds, rhinitis, waking up with a dry mouth as a
proxy for mouth breathing, cough, wheeze, triggers of cough and wheeze [3, 7]
Asthma diagnosis and hay fever [3, 7]
Medication during the day of the visit: inhaled short- and long-acting beta-2 agonists, inhaled corticosteroids,
leukotriene receptor antagonists
Environment and lifestyle: frequency of active smoking of cigarettes, shishas and e-cigarettes; paternal and
maternal smoking
2. Anthropometrics Height and weight measured in the bus without wearing shoes
Body mass index z-scores calculated using World Health Organization reference tables [37]
3. Lung function measurements Spirometry Masterlab, Jaeger, Würzburg, Germany. Mouthpiece, filter, nasal clamp
Main outcomes: forced expiratory flows and volumes [28]
FeNO Fast response chemiluminescence analyzer CLD 88, Eco Medics AG, Duernten, Switzerland. Mouthpiece,
filter, no nasal clamp
Main outcome: mean FeNO (ppb) of at least two reproducible exhalations in the same child [27, 43]
DTG-SBW
(He, SF6)
Exhalyzer D, Eco Medics AG, Duernten, Switzerland. Mouthpiece, filter, nasal clamp [23]
Main outcome: phase III slope
4. Air pollution We will use data from air pollution models developed by de Hoogh et al. [30, 31] to estimate participants’ av-
erage exposure to NO2 and PM2.5 for specific time windows and locations, based on participants’ exact ad-
dress history.
5. Swiss-SEP An area-based measure of socioeconomic status based on data about rent per square meter, education and
occupation of households’ heads, and household crowding, which ranges from 0 (lowest) to 100 (highest),
developed as part of the Swiss National Cohort study [20, 21]
FeNO = Fractional exhaled nitric oxide; ppb = parts per billion; DTG-SBW = double tracer gas single breath washout; He = helium; SF6 = sulphur hexafluoride; NO2 = nitrogen
dioxide; PM2.5: particulate matter of aerodynamic diameter of 2.5 µm or less; Swiss-SEP = socioeconomic position in Switzerland
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following order: (1) double tracer gas single-breath
washout (DTG-SBW), (2) fractional exhaled nitric oxide
(FeNO), and (3) spirometry.
DTG-SBW
DTG-SBW was measured using a validated and commer-
cially available setup (Exhalyzer D®, Eco Medics AG,
Duernten, Switzerland) [22]. The patient interface consist-
ed of a bacterial filter and a snorkel mouthpiece to pre-
vent air leaks near the mouth. According to current pae-
diatric equipment recommendations, a dead space reducer
and a disposable hygienic insert provided by the manufac-
turer were used [23]. The DTG mixture contained 26.3%
helium (He), 5% sulphur hexafluoride (SF6), 21% oxygen
(O2), and balance dinitrogen (N2) from pressurised cylin-
ders (Carbagas, Bern, Switzerland). Children watched a
video for distraction while breathing through an open by-
pass system. Directly before tracer gas wash-in, the appa-
ratus dead space and the bias flow was flushed with dou-
ble-tracer gas or 100% O2 during expiration to prevent
re-inspiration of expired or ambient gas [24]. DTG-SBW
was performed in accordance with the European Respira-
tory Society (ERS) consensus on inert gas washout testing
[23]: after establishing natural tidal breathing for at least 5
breaths monitored by online flow-volume loops and tidal
volumes varying less than 10%, the system was flushed
with the DTG mixture. Within only one breath, the chil-
dren inhaled the double-tracer gas and exhaled it back.
SBW tests were done in triplicate. Each test was followed
by at least 10 breaths of room air, until the online moni-
toring of the gas signals returned to baseline [23]. Prima-
ry outcome of the DTG-SBW was the mean slope from
the tidal (alveolar) phase III from three technically accept-
able DTG-SBW curves, normalised for tidal volume (SnI-
II) [25]. The magnitude of phase III slopes from He and
SF6 relates to acinar branching asymmetry and small air-
ways obstruction [26]. DTG-SBW is a fast and easy to per-
form test with low variability and high repeatability [22].
FeNO
FeNO was measured with a single breath on-line method
according to recommendations [27]. We used a fast re-
sponse chemiluminescence analyser CLD 88, Eco Medics
AG, Duernten, Switzerland. The field workers calibrated
the FeNO device every morning and the gas was calibrated
once per month. Children breathed air free of nitric oxide
via the Denox system (EcoMedics, Dürnten). This setup
also included a bacterial filter and disposable hygienic
mouthpiece. After 10 breaths, children exhaled against an
adjusted expiratory resistance with a constant target flow
of 50 ml/sec for at least 4 seconds for children younger
than 12 years and 6 seconds for children aged 12 years or
older. We aimed for at least two reproducible exhalations
with the nitric oxide plateau values within 10% of each
other. Results were stored digitally, including information
on FeNO (parts per billion, ppb), expiratory time (sec-
onds), duration of the plateau (seconds), and average flow
in the plateau (ml/s). The primary outcome was FeNO.
Spirometry
Spirometry was performed using Masterlab, Jaeger,
Würzburg, Germany according to American Thoracic So-
ciety (ATS) / ERS recommendations [28]. The children
performed three to five forced expiratory manoeuvres.
Spirometry parameters were recorded and stored digitally
using the Sentry Suite software, Carefusion, Hoechberg,
Germany. Spirometry parameters included forced vital ca-
pacity (FVC), forced expiratory volume in the first second
(FEV1), peak expiratory flow (PEF), FEV1/FVC ratio,
maximum expiratory flow at 75%, 50% and 25% FVC
(FEF75, FEF50, FEF25) and between the 25% and 75% of
FVC (FEF25–75). The spirometry flow-volume curve of the
best effort was printed on paper. Primary outcomes were
forced expiratory flows and volumes. Absolute values of
spirometry parameters were expressed as z-scores accord-
ing to Global Lung Initiative reference values [29].
Air pollution assessment
Spatiotemporal data on nitrogen dioxide (NO2) and par-
ticulate matter with an aerodynamic diameter of 2.5 µm
or less (PM2.5) will be obtained from models developed
by de Hoogh et al. [30, 31]. Daily average NO2 concen-
trations were modelled across Switzerland using a mul-
tistage framework with mixed-effect and random forest
models at a fine spatial resolution of 100 × 100 m [30]
combining the Ozone Monitoring Instrument (OMI) NO2
product with Copernicus Atmosphere Monitoring Service
(CAMS), land use and meteorological variables. Daily
PM2.5 concentrations across Switzerland were estimated
first by a combination of a mixed effect model and a gen-
eralised additive mixed model at a 1 × 1 km resolution us-
ing Multiangle Implementation of Atmospheric Correction
(MAIAC), spectral aerosol optical depth (AOD) data, and
second by support vector machine algorithms used to pre-
dict precise exposure estimates at a 100 × 100 m resolution
with spatiotemporal predictor data [31]. These air pollution
models allow estimation of participants’ average exposure
to NO2 and PM2.5 for specific time windows and locations.
We will link the geocoded residential and school addresses
of study participants to NO2 and PM2.5 data by GIS (geo-
graphic information system) overlay.
Ethics and data safety
The ethics committee of the canton of Zurich approved
the study (KEK-ZH-Nr: 2014-0491). Parents signed the in-
formed consent form and completed a detailed question-
naire. Children assented orally and those aged 15 years or
older also signed. Participant identifiable information was
stored in a separate database and only pseudoanonymised
datasets are used for analysis. Paper-based data were se-
curely locked at ISPM and only accessible to the study
team. Raw data of DTG-SBW, FeNO and spirometry mea-
surements were stored in a safe study server during recruit-
ment and were thereafter encrypted and securely stored in
the ISPM protected server. Access to the server and the
study databases is restricted to members of the study team.
Study datasets are securely stored and routinely backed up
in protected servers of ISPM Bern. Study collaborators and
other researchers can obtain datasets for analysis if a de-
tailed concept sheet is presented for the planned analyses
and approved by the principal investigators (AM, PL and
CK).
Sample size considerations
We aimed to recruit over 3000 children to address the main
objectives of the LUIS study. In this section we describe
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examples of sample size estimations for our main aims
[32]. LUIS aimed to describe the frequency of respirato-
ry symptoms in schoolchildren. To estimate the prevalence
of current wheeze we need a sample size of 2501 partici-
pants, if we assume a level of acceptable error of 1% [3],
and we expect a proportion of wheeze in the population of
around 7% [14], at the 5% type I error rate (i.e., α = 0.05).
Another study aim was to assess risk factors for respiratory
symptoms. If we expect the proportion of wheeze to be 7%
higher among students who smoke compared with never
smokers [33], and a proportion of smokers of 15% [34], to
be 80% certain of detecting a prevalence difference at the
5% Type I error rate, we need a sample with 160 smokers
and 890 never smokers. LUIS also aimed to examine asso-
ciations between lung function measurements and environ-
mental exposures. If we want to compare the difference in
FEV1 (ml) between a group of participants with high ex-
posure to air pollution (e.g., PM2.5) with a group with low-
er exposure levels, using a two-sided 5% significance test
(i.e., α = 0.05), to be 80% sure of detecting a difference of
−50ml between the high and the low exposure groups, with
an estimated standard deviation of FEV1 of 326 ml [35],
we need at least 668 participants per group. LUIS data will
be used to assess the fit of global lung function initiative
(GLI) reference equations, for which we need at least 150
healthy boys and girls of white ethnicity [29, 36]. If we
want to assess the fit of GLI for several age groups, at least
300 children per age group are needed. At follow-up, we
aimed to re-visit a sub-sample of 1000 children for longi-
tudinal analyses.
Data preparation and analysis
We calculated body mass index (BMI) z-scores according
to World Health Organization references and categorised
BMI z-scores ≥2 as obesity, ≥1 to <2 as overweight and
≤−2 as underweight [37]. In this manuscript, we compared
participants’ characteristics between age groups using p-
values for a trend. We used the software STATA (Version
16.1, StataCorp., College Station, TX) for statistical analy-
sis. In our planned analyses, we will select confounders
a priori based on Directed Acyclic Graphs (DAGs). Re-
sults from DTG-SBW, FeNO or spirometry tests that did
not meet the quality standards described in the appendix
will not be included in analyses. Details on data quality as-
sessments can be found in the appendix. We will adhere to




All 490 schools in the canton of Zurich were invited to par-
ticipate (supplementary table S1 in the appendix). At base-
line, 37 schools took part and 3870 participants consented.
One year later, 19 schools were visited a second time and
655 children were followed up. The canton of Zurich (fig.
2) had mostly schools in small (47%) and large urban areas
(41%) and fewer in rural areas (12%) (fig. 3, online Table
S1) [39, 40]. At baseline, LUIS visited 18 schools in small
(49%) and 15 in large (40%) urban areas and 4 in rural ar-
eas (11%). At follow up, 13 schools in small (68%) and 4
in large (21%) urban areas and 2 in rural areas (11%) were
visited. Median Swiss-SEP was 66.2 (interquartile range
[IQR] 58.2–73.0) for households with at least one school-
aged child in the canton of Zurich, 69.2 (IQR 61.2–76.3)
for LUIS participants at baseline and 69.4 (IQR 64.7–74.8)
at follow-up (fig. 4, supplementary fig. S2).
Completeness of datasets
At baseline, 3457 participants (89%) provided parental
questionnaires, 3546 (92%) answered the children’s ques-
tionnaire, 3446 (89%) did spirometry, 3393 (88%) FeNO
and 1795 (46%) DTG-SBW tests (supplementary table S2
Figure 2: Areas from the canton of Zurich that were visited by the
LuftiBus in the School (LUIS) study. The area of the circle is pro-
portional to the number of participants per location. The colour of
the circle indicates the degree of urbanisation of the region (from
darker to lighter grey: large urban, small urban, rural areas) ac-
cording to the Swiss Federal Office of Statistics classification. Defi-
nition of urbanisation degree: cities or large urban area: at least
50% lives in high-density clusters. Towns and suburbs or small ur-
ban area: less than 50% of the population living in rural grid cells
and less than 50% living in a high-density cluster. Rural area: more
than 50% of the population living in rural grid cells.
Figure 3: Proportion of schools by degree of urbanisation in the
canton of Zurich and in the LuftiBus in the School (LUIS) study at
baseline and follow-up. Definition of urbanisation degree: cities or
large urban area: at least 50% lives in high-density clusters. Towns
and suburbs or small urban area: less than 50% of the population
living in rural grid cells and less than 50% living in a high-density
cluster. Rural area: more than 50% of the population living in rural
grid cells.
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in the appendix). At the 1-year follow-up, data from
parental questionnaires was available for 629 children
(96%), data from children’s questionnaires for 640 (98%),
results from spirometry for 614 (94%), results from FeNO
testing for 588 (90%) and results from DTG-SBW for 496
children (76%).
Figure 4: Box plots showing the distribution of Swiss socioeco-
nomic position index (Swiss-SEP) for families with at least one
child aged 6–17 years and living in the canton of Zurich and in the
LuftiBus in the School (LUIS) study at baseline and follow-up. The
median is represented by a horizontal line inside the box, 25 and
75 percentiles by the upper and lower box horizontal lines of the
box, minimum and maximum values are shown as whiskers, and
points outside the whiskers are outliers.
Characteristics of study participants and first results
LUIS included 987 children aged 6–9 years (2%), 1723
aged 10–13 years (45%) and 1160 aged 14–17 years (30%)
at baseline (table 2). Current wheeze was reported by par-
ents of 281 (8%) children. Exercise-induced wheeze was
more common among older children, and night cough
among younger children. Use of inhaled short-acting be-
ta-2 agonists (SABA) and inhaled corticosteroid (ICS) in
the past year was reported by parents of 257 (8%) and 179
(5%) children, respectively. Parents of 1108 (32%) report-
ed that their child had a high physical activity level. This
was more common for younger children. Mothers of 574
(17%) and fathers of 758 (22%) children reported smok-
ing. A total of 580 children (15%) were overweight and
194 (5%) obese, with obesity being more common in old-
er children. Most children were born in Switzerland (n =
3042; 88%), but only over half of children’s mothers (n =
1934; 56%) and fathers (n = 2045; 59%).
The volume of air that was exhaled in the first second
(FEV1) was higher in boys (median 2556 ml, IQR
1963–3358) than in girls (2485 ml, IQR 1910–2953) and
increased with age, particularly during the pubertal growth
spurt (fig. 5).
FeNO had a right skewed distribution. Median (IQR) val-
ues of FeNO were 12.9 ppb (7.3–24) in boys and 12.0
ppb (7.0–19.2) in girls (fig. 6). FeNO levels were lower in
younger than in older in children with reported hay fever
(age 6–9 years: median 11.9 ppb, IQR 6.5–24.3; age 10–13
years: 20.9 ppb, 10.6–43.9; age 14–17 years: 20.1 ppb,
11.6–39.3) and also in children without hay fever (age 6–9
Table 2: LuftiBus in the School (LUIS) study: characteristics of the study participants.
Total Age groups (years) P trend
6 to 9 10 to 13 14 to 17
n = 3870 n = 987 n = 1723 n = 1160
Male sex 1937 (50%) 509 (52%) 842 (49%) 586 (51%) -
Age in years, mean (SD) 12.1 (2.7) 8.2 (1.0) 12.4 (1.2) 15.0 (0.7) -
Height for age z-scores, mean (SD) 0.55 (1.0) 0.76 (1.0) 0.51 (1.1) 0.45 (1.0) <0.001
Body mass index z-scores, mean (SD) 0.06 (1.2) –0.06 (1.1) 0.04 (1.2) 0.19 (1.1) <0.001
Body mass index Underweight (z-score ≤−2) 139 (4%) 34 (4%) 76 (4%) 29 (3%) 0.002
Normal weight (z-score >−2,
<1)
2850 (76%) 752 (80%) 1251 (74%) 847 (75%)
Overweight (z-score ≥1, <2) 580 (15%) 126 (13%) 276 (16%) 178 (16%)
Obese (z-score ≥2) 194 (5%) 33 (3%) 93 (5%) 68 (6%)
Level of physical activity Low 332 (10%) 26 (3%) 140 (9%) 166 (18%) <0.001
Moderate 1976 (58%) 484 (51%) 928 (60%) 564 (61%)
High 1108 (32%) 443 (46%) 475 (31%) 190 (21%)
Practice of sports outside school 2612 (76%) 767 (81%) 1216 (79%) 629 (68%) <0.001
Symptoms in the past 12 months Wheeze 281 (8%) 75 (8%) 137 (9%) 69 (8%) 0.864
Exercise-induced wheeze 274 (8%) 43 (5%) 134 (9%) 97 (11%) <0.001
Night cough apart from colds 394 (12%) 142 (15%) 154 (10%) 98 (11%) 0.003
Rhinitis apart from colds 1049 (31%) 217 (23%) 501 (33%) 331 (36%) <0.001
Habitual snoring (almost every
night)
163 (5%) 55 (6%) 60 (4%) 48 (5%) 0.584
Use of inhaled medication in the
past 12 months
Short acting beta-2 agonists 257 (8%) 63 (7%) 123 (8%) 71 (8%) 0.344
Inhaled corticosteroids 179 (5%) 36 (4%) 90 (6%) 53 (6%) 0.050
Hay fever 767 (23%) 134 (14%) 373 (25%) 260 (28%) <0.001
Maternal smoking 574 (17%) 121 (13%) 266 (17%) 187 (20%) <0.001
Paternal smoking 758 (22%) 171 (18%) 335 (22%) 252 (27%) <0.001
Pets in the household 1469 (43%) 313 (33%) 720 (47%) 436 (47%) <0.001
Living on a farm 85 (2%) 12 (1%) 46 (3%) 27 (3%) 0.021
Information obtained from the parental questionnaires at baseline. P trend: p value for a trend across ordered categories of age groups. Height for age and body mass index
z-scores were based on WHO references.
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years: median 7.9 ppb, IQR 5.0–13.6; age 10–13 years:
11.6 ppb, 6.9–18.2; age 14–17 years: 14.3 ppb, 9.2–21.8).
Discussion
LUIS is a large school-based study performed in
2013–2016 in the canton of Zurich, Switzerland, which
comprised a thorough assessment of respiratory symptoms,
lung function, lifestyle and environmental exposures.
LUIS data will help to increase knowledge on respiratory
health in schoolchildren by assessing risk factors, studying
phenotypes, contributing to normative lung function and
airway inflammation data, and providing recommenda-
tions for future research.
Strengths and weaknesses
The main strength of LUIS is the wealth of health data that
were collected, which includes three different lung func-
tion tests: spirometry, FeNO measured using high reso-
lution equipment and the novel DTG-SBW. This permits
the investigation of different physiological aspects of lung
health. A subsample of participants had repeat lung func-
tion measurements a year later, which allows assessment of
lung growth. We collected detailed questionnaire data on
respiratory symptoms, diagnoses and lifestyle from both
parents and children, which allows comparisons between
their answers. Information was collected on lower respira-
tory symptoms such as wheeze and chronic cough, and on
Figure 5: Distribution of forced expiratory volume in one second
(FEV1) by age and sex in children from the LuftiBus in the School
(LUIS) study at baseline. FEV1 measured in litres (L)
Figure 6: Distribution of fractional exhaled nitric oxide (FeNO) by
sex in children from the LuftiBus in the School (LUIS) study at
baseline. FeNO measured in parts per billion (ppb).
upper respiratory symptoms such as rhinitis, hay fever and
snoring. Respiratory symptoms are influenced by season-
ality, but the LuftiBus visited the schools throughout dif-
ferent seasons, which makes it possible to take seasonality
into account in our analyses. Participants’ address histories
enable us to use state-of-the-art methods [30, 31] to esti-
mate air pollution exposure during specific time windows.
The main weakness is that it was not a perfectly random
sample of schoolchildren. Participation was decided by the
heads of the schools, and classes were recruited as a whole.
We do not have individual data on non-participating stu-
dents, which limits the possibilities to assess representa-
tiveness of the sampled population. However, the distrib-
ution of participating schools in rural and urban areas at
baseline was similar to the average distribution of schools
in the canton of Zurich. At follow-up, schools from small
urban areas were slightly overrepresented in our study.
The cost associated with the health promotion activity in
which the LUIS study was embedded was covered by the
public budget for health prevention activities available to
school heads. This cost and time availability might have
contributed to a school head’s decision to participate to the
study. The area-based socioeconomic index of participat-
ing families was roughly comparable to that of all house-
holds with school-aged children from the canton of Zurich.
Thus, we think LUIS gives a fair picture of the school-
aged population from the canton of Zurich. We recruited
over 3000 participants at baseline, but the sub-sample fol-
lowed-up was smaller than originally planned because of
budget restraints, which limits the possibility of longitu-
dinal analyses. Another limitation is the lack of objective
measurements of atopy such as skin prick tests or serum
IgE levels. This limits the interpretation of FeNO data. We
had, however, proxy measures of atopy, namely reported
hay fever and atopic dermatitis.
Outlook
LUIS will cover knowledge gaps on children’s respiratory
health. This dataset allows determination of the prevalence
of upper and lower respiratory symptoms, description of
lifestyle characteristics such physical activity and smoking
[41], and a study of associations with lung function. We are
able to use information from both parents and children and
several lung function tests, including markers of ventilato-
ry function (spirometry), ventilation inhomogeneity (DTG-
SBW) and Th2 airway inflammation (FeNO), to answer
research questions in a comprehensive way [42, 43]. For
example, DTG-SBW data allows detection of even subtle
changes in peripheral airways, which may not be identified
by spirometry alone [42]. The broad set of data collected
allows us to describe lung function in healthy children, and
to report normal values. The LUIS study makes it also pos-
sible to study effects of air pollution on respiratory symp-
toms and lung function.
In conclusion, LuftiBus in the School (LUIS) provides a
unique opportunity to assess the respiratory health of Swiss
schoolchildren, and its association with health behaviours
and air pollution. Better understanding of factors that influ-
ence Swiss schoolchildren’s respiratory health may help to
establish new recommendations and influence policy mak-
ers’ decisions.
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Additional methods 
LuftiBus in the school (LUIS) is a study funded by Lunge Zürich, a non-profit organization that promotes 
respiratory health prevention and research. LUIS used a special bus (“LuftiBus”) to visit schools within 
the canton of Zurich. Inclusion criteria were consent to participate and age 6 to 17 years. There were no 
predefined exclusion criteria.  
LuftiBus 
LuftiBus is a broader project of Lunge Zürich for the prevention and early detection of lung diseases and 
has been ongoing for 30 years [1, 2]. LuftiBus offers lung function tests to adults of the general public 
living in the metropolitan region of Zurich at a non-profit cost of 10 CHF [3]. Previous research has used 
data from the LuftiBus lung function campaign to calculate reference equations for lung function [3, 4]. 
LuftiBus data was linked with data form the Swiss National Cohort [5] to assess time trends in the 
prevalence of airway obstruction among adults from the general population [6], occupational risk 
factors for airway obstruction [7], and spatial risk pattern of respiratory morbidity [8].  
Data collection: double tracer gas single breath washout (DTG-SBW)  
The gas mixture had the same molar mass (MM, g.mol-1) as medical-grade air, such that any detectable 
changes compared with normally expired molar mass can be attributed to relative changes in helium 
(He) and sulphur hexafluoride (SF6) concentrations [9]. MM was measured by a side-stream ultrasonic 
flowmeter, tidal flows by a main-stream ultrasonic flowmeter. On each test day, signal calibration and 
verification were performed prior to testing. The main-stream ultrasonic flowmeter was calibrated using 
a 1 L precision syringe. The side-stream ultrasonic flowmeter and the oxygen (O2) and carbon dioxide 
(CO2) sensors were calibrated using medical-grade calibration gas and pure O2 (Carbagas, Bern, 
Switzerland). 
Air pollution assessments 
Individual air pollution exposure will be estimated for nitrogen dioxide (NO2) and for particulate matter 
with an aerodynamic diameter of 2.5 µm or less (PM 2.5) using air pollution models developed by de 
Hoogh et. al [10, 11]. Daily average NO2 concentrations from 2005 to 2016 were modelled in a 
multistage framework with mixed-effect and random forest models at a fine spatial resolution (100x100 
m) [10]. The model incorporates spatial and temporal predictors including satellite-derived data from 
the Ozone Monitoring Instrument and Copernicus Atmosphere Monitoring Service, and road, land use, 
topography and meteorological information. Daily NO2 monitoring data were obtained from the 
Immisionsdatabank Luft (IDB Luft, FOEN, Bern, Switzerland) measured at 67 sites in 2005 and increased 
to 110 sites in 2016. The model was able to explain approximately 73% of the overall spatiotemporal 
variation in NO2 measurements [10].  
Spatiotemporal resolved models were developed to predict daily PM 2.5 exposure [11]. First, daily PM 
2.5 concentrations were estimated by a combination of a mixed effect model and a generalized additive 
mixed model at a 1×1km resolution across Switzerland using Multiangle Implementation of Atmospheric 
Correction (MAIAC) spectral aerosol optical depth (AOD) data. Second, support vector machine 
algorithms were used to predict precise exposure estimates at a 100 x 100m resolution in using 
spatiotemporal predictor data. The global (1 km) and local (100 m) models explain on average 73% of 
the total, 71% of the spatial and 75% of the temporal variation globally, and on average 89% of the total, 
Swiss Medical Weekly  Swiss Med Wkly. 2021;151:w20544, Appendix Page A-3 
 
Published under the copyright license "Attribution - Non-Commercial - No Derivatives 4.0".  
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html. 
95% of the spatial and 88% of the temporal variation locally in measured PM 2.5 concentrations [11]. 
From these data we will calculate the mean exposure of each subject to specified air pollution during 
specific exposure windows. 
Other available data on air pollution include ozone in parts per billion, fine particles (number of particles 
per cm3, average particle diameter in nm, lung-deposited particle surface in um2/cm3), and temperature 
and humidity measurements obtained at schools on the day of the study visit using a wireless collection 
system installed on the roof of the bus in collaboration with the OpenSense team of the ETH (Swiss 
Federal Institute of Technology in Zurich). The system sent data continuously to a central database at 
the ETH and sensors were calibrated when the bus passed a reference station.  
Data quality 
Parental questionnaires 
The data entry form of the parental questionnaire contained automatic plausibility checks to reduce 
data entry errors. We did double data entry for a random 10% of the parental questionnaires using the 
software Epidata. Variables had one to five entry fields. We found a low field error percentage (1%) and 
thus did not double enter the remaining 90% of questionnaires.  
DTG-SBW 
Quality control of DTG-SBW measurements was performed by the field workers on site. A double check 
of DTG-SBW test results is on-going, to see if the phase III was linear and constituted at least 50% of 
expired volume [9, 12]. Quality control criteria for DTG-SBW were defined as: 1) no evidence of air leaks 
as monitored by volume and MM signals, 2) similar flow-volume-loops in pre-test and test breaths, 3) 
breath volumes of the five tidal pre-test and the test breaths were within 10%, 4) inspiratory peak flow 
within the by-pass flow. 
For signal processing and analyses we used software developed by our group (LungSim, Numerical 
Modeling, Thalwil, Switzerland) running in (Matlab® R2014a, The Mathworks Inc., Natick, MA, USA) [9]. 
MM, CO2 and volume signals were aligned in time accounting for different signal rise times [9]. To 
extract the double-tracer gas signal from MM we subtracted the naturally exhaled CO2 fraction from the 
MM signal [9]. The corrected MM and CO2 expirograms were plotted against expired volume (Figure S3). 
The SDTG was computed automatically by linear regression between 65 to 95% of expired volume and 
under visual control. If required, we manually adjusted  volume limits to exclude adjacent tidal phases. 
Quality criteria were presence of both MM and CO2 phase III over at least 50% of expired volume.  
Fractional exhaled nitric oxide (FeNO)  
Required average flow in the plateau was 40-60 ml/s and required duration of exhalation was at least 4 
seconds for children younger than 12 years and 6 seconds for children aged 12 years or older. Mean 
FeNO was calculated using at least two reproducible exhalations with the nitric oxide plateau values 
within 10% of each other. Field workers checked the quality of the FeNO measurements on site 
according to ATS/ERS criteria for online FeNO measurement in children [13].  
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Spirometry flow-volume curves 
In a dedicated workshop, a paediatric pulmonologist and lung function expert (FS) explained the 
fundamental concepts of paediatric spirometry quality control to all participants. Five pairs of team 
members assessed and scored by consensus the quality of spirometry curves into “good”, “moderate” 
or “bad” quality” depending on the presence of hesitation at start of expiration, submaximal effort, 
forced flow deviations (e.g. cough or glottis closure) within or after the first second, and premature 
ending of the exhalation within or after the first second. Three paediatric respiratory physicians (FS, CK, 
JU) assessed all spirometry curves marked as “moderate” or “bad” quality during the first screening and 
set their own score. If the paediatric respiratory physicians had doubts on the scoring of a spirometry 
curve, they discussed the curve among them and reached an agreement. 
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Table S1: Characteristics of schools in the canton of Zurich and visited by the LuftiBus in the school study (LUIS) at baseline and 
at one-year follow-up, by degree of urbanisation. 
 
Urbanisation degree Total 
  Large urban Small urban Rural 
 
Schools in canton of Zurich         
Number of schools: n (%) 201 (41) 228 (47) 61 (12) 490 
Number of classes: n (%) 2450 (45) 2602 (48) 381 (7) 5433 
Number of students: n (%) 48718 (45) 51588 (48) 7333 (7) 107639 
Average number of students per class 19.9  19.8  19.2  19.8 
Schools visited by LUIS, baseline        
Number of schools: n (%) 15 (40) 18 (49) 4 (11) 37 
Number of classes: n (%) 149 (39) 204 (54) 26 (7) 379 
Number of students: n (%) 2959 (40) 3842 (53) 536 (7) 7337 
Average number of students per class 19.9  18.8  20.6  19.4 
Schools visited by LUIS, follow-up        
Number of schools: n (%) 4 (21) 13 (68) 2 (11) 19 
Number of classes: n (%) 45 (23) 143 (73) 7 (4) 195 
Number of students: n (%) 917 (24) 2679 (72) 143 (4) 3739 
Average number of students per class 20.4  18.7  20.4  19.2 
 
Calculations are based on aggregated data provided by the Swiss federal statistical office. The number of schools in the canton 
of Zurich corresponds to the year 2013. Definition of urbanization degree [14]: Large urban area: At least 50% lives in high-
density clusters. Small urban area: Less than 50% of the population lives in rural grid cells and less than 50% lives in a high-
density cluster. Rural area: More than 50% of the population lives in rural grid cells.  
 
  
Swiss Medical Weekly  Swiss Med Wkly. 2021;151:w20544, Appendix Page A-6 
 
Published under the copyright license "Attribution - Non-Commercial - No Derivatives 4.0".  
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html. 
Table S2: Number of participants in the LuftiBus in the school (LUIS) study with available information on parental 
questionnaires (PQ), children’s questionnaires (CQ), spirometry (Spiro), and fractional exhaled nitric oxide (FeNO) at baseline 
and at the one-year follow-up. 




n (%) n (%) 
PQ         3457 (89) 629 (96) 
CQ         3546 (92) 640 (98) 
Spiro         3446 (89) 614 (94) 
FeNO         3393 (88) 588 (90) 
DTG-SBW         1795 (46) 496 (76) 
PQ & CQ       3171 (82) 614 (94) 
PQ & Spiro            3071 (79) 589 (90) 
PQ & FeNO       3030 (78) 565 (86) 
PQ & DTG-SBW       1627 (42) 472 (72) 
CQ & Spiro            3230 (83) 610 (93) 
CQ & FeNO       3183 (82) 584 (89) 
CQ & DTG-SBW       1784 (46) 492 (75) 
Spiro      & FeNO       3165 (82) 561 (86) 
Spiro & DTG-SBW       1585 (41) 472 (72) 
FeNO & DTG-SBW       1595 (41) 451 (69) 
CQ & Spiro      & FeNO     2964 (77) 557 (85) 
CQ & Spiro      & DTG-SBW     1579 (41) 469 (72) 
CQ & FeNO & DTG-SBW     1585 (41) 448 (68) 
PQ & Spiro      & FeNO     2824 (73) 539 (82) 
PQ & Spiro      & DTG-SBW     1429 (37) 449 (69) 
PQ & CQ & Spiro          2882 (74) 585 (89) 
PQ & CQ & FeNO     2845 (74) 561 (86) 
PQ & FeNO & DTG-SBW     1429 (37) 429 (65) 
Spiro & FeNO & DTG-SBW     1460 (38) 430 (66) 
PQ & CQ & Spiro      & FeNO   2646 (68) 535 (82) 
PQ & CQ & FeNO & DTG-SBW   1421 (37) 426 (65) 
PQ & Spiro      & FeNO & DTG-SBW   1305 (34) 409 (62) 
PQ & CQ & FeNO      & DTG-SBW   1421 (37) 426 (65) 
CQ & Spiro      & FeNO & DTG-SBW   1454 (38) 427 (65) 
PQ & CQ & Spiro      & FeNO & DTG-SBW 1300 (34) 406 (62) 
 
Number of measurements before quality control.  
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Figure S1: Poster of asthma medications used in the LuftiBus in the school (LUIS) study to help children 
answer which medication they had taken the day of the visit (in German).  
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Figure S2: Histograms showing the distribution of the Swiss socioeconomic position index for families 
from the canton of Zurich with at least one child aged 6-17 years living in the household and in the 
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Figure S3: Fit lines of double tracer gas single breath washout (DTG-SBW), differences in molar mass 
(MM) plotted against expired volume. 
Abbreviations: MMss = Molar mass signal of the side stream; MMss calc = Calculated molar mass signal of the side 
stream using measured gas proportion of a normal breath; Diff MMss = MMss – MMss calc; End Tidal Diff MMss: 
Difference of MMss – MMss calc (in %) at the end of expiration; Interception point (%): % of expired volume where 
Diff MMss = 0; Diff MMss Max Vol (% Exp Vol): Difference of MMss-MMss calc at the maximum expired volume; 
Left and right bound= 65-95% of expired volume. 
 
